Skip to main content

UBS Group AG

Position in BTAI — BioXcel Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in BTAI

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$222,870
+$152,136 QoQ
Shares Held
158,065
+199.4% QoQ
Ownership
0.505%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 47 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BTAI Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

UBS Group AG holds $1,471,514,369 across 82 Drug Manufacturers - Specialty & Generic names. BTAI ranks #51 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BTAI

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $222,870 158,065
2026-03-31 $70,734 52,788
2025-12-31 $61,344 38,340
2025-09-30 $111,466 43,542
2025-06-30 $72,185 39,882
2025-03-31 $206,608 101,778
2024-12-31 $477,556 1,276,893
2024-09-30 $8,068 13,228
2024-06-30 $67,177 52,483
2024-03-31 $414,981 147,157
2023-12-31 $142,543 48,320
2023-09-30 $198,868 78,604
2023-06-30 $738,833 110,936
2023-03-31 $2,990,991 160,289
2022-12-31 $2,990,315 139,214
2022-09-30 $1,694,845 143,388
2022-06-30 $1,544,664 117,020
2022-03-31 $3,775,592 180,564
2021-12-31 $4,064,637 199,933
2021-09-30 $6,547,253 215,725
2021-06-30 $4,667,122 160,603
2021-03-31 $8,518,445 197,369
2020-12-31 $4,248,043 91,949
2020-09-30 $3,811,473 87,903
2020-06-30 $4,287,130 80,874
2020-03-31 $1,934,056 86,535